
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL(L) | 1,749 | 99.1% | -0.05 | 1,689 | 99.8% |
| CentralBrain-unspecified | 16 | 0.9% | -2.00 | 4 | 0.2% |
| upstream partner | # | NT | conns ORN_VL1 | % In | CV |
|---|---|---|---|---|---|
| ORN_VL1 | 20 | ACh | 6.0 | 14.1% | 0.7 |
| lLN2F_a (L) | 2 | unc | 5.7 | 13.3% | 0.2 |
| lLN2R_a (L) | 3 | GABA | 5 | 11.7% | 0.4 |
| lLN2P_b (L) | 3 | GABA | 4.8 | 11.2% | 0.5 |
| lLN2X12 (L) | 6 | ACh | 4.1 | 9.5% | 0.5 |
| lLN2X04 (L) | 2 | ACh | 2.5 | 5.8% | 0.2 |
| lLN2X11 (L) | 2 | ACh | 2.3 | 5.3% | 0.0 |
| ALIN5 (R) | 1 | GABA | 2.2 | 5.1% | 0.0 |
| lLN2T_d (L) | 2 | unc | 1.9 | 4.4% | 0.5 |
| lLN2T_e (L) | 2 | ACh | 1.9 | 4.3% | 0.2 |
| lLN1_bc (L) | 11 | ACh | 1.1 | 2.7% | 0.5 |
| lLN2F_b (L) | 2 | GABA | 0.9 | 2.1% | 0.9 |
| lLN2T_a (L) | 3 | ACh | 0.8 | 1.9% | 0.2 |
| lLN2X05 (L) | 2 | ACh | 0.7 | 1.7% | 0.6 |
| VL1_ilPN (L) | 1 | ACh | 0.7 | 1.6% | 0.0 |
| VL1_ilPN (R) | 1 | ACh | 0.5 | 1.2% | 0.0 |
| il3LN6 (L) | 1 | GABA | 0.5 | 1.2% | 0.0 |
| OA-VUMa2 (M) | 2 | OA | 0.4 | 1.0% | 0.8 |
| AL-MBDL1 (R) | 1 | ACh | 0.1 | 0.2% | 0.0 |
| v2LN39a (L) | 2 | Glu | 0.1 | 0.2% | 0.0 |
| DNc02 (R) | 1 | unc | 0.1 | 0.2% | 0.0 |
| CB4083 (L) | 1 | Glu | 0.1 | 0.2% | 0.0 |
| VP4+VL1_l2PN (L) | 1 | ACh | 0.0 | 0.1% | 0.0 |
| DNc01 (R) | 1 | unc | 0.0 | 0.1% | 0.0 |
| GNG328 (L) | 1 | Glu | 0.0 | 0.1% | 0.0 |
| v2LN40_2 (L) | 1 | unc | 0.0 | 0.1% | 0.0 |
| M_lPNm11A (L) | 1 | ACh | 0.0 | 0.1% | 0.0 |
| v2LN4 (R) | 1 | ACh | 0.0 | 0.1% | 0.0 |
| VP4+VL1_l2PN (R) | 1 | ACh | 0.0 | 0.1% | 0.0 |
| lLN2P_a (L) | 1 | GABA | 0.0 | 0.1% | 0.0 |
| vLN24 (L) | 1 | ACh | 0.0 | 0.1% | 0.0 |
| downstream partner | # | NT | conns ORN_VL1 | % Out | CV |
|---|---|---|---|---|---|
| VL1_ilPN (L) | 1 | ACh | 28.0 | 14.0% | 0.0 |
| VL1_ilPN (R) | 1 | ACh | 23.5 | 11.8% | 0.0 |
| CB4083 (L) | 7 | Glu | 22.1 | 11.1% | 0.5 |
| v2LN40_2 (L) | 2 | unc | 21.9 | 10.9% | 0.2 |
| CB4083 (R) | 7 | Glu | 12.5 | 6.3% | 0.5 |
| lLN2R_a (L) | 3 | GABA | 6.9 | 3.4% | 0.5 |
| v2LN33 (L) | 2 | ACh | 6.7 | 3.4% | 0.0 |
| lLN2T_a (L) | 3 | ACh | 6.2 | 3.1% | 0.4 |
| v2LN42 (L) | 3 | Glu | 6.1 | 3.1% | 0.6 |
| ORN_VL1 | 19 | ACh | 6.0 | 3.0% | 0.6 |
| lLN2X04 (L) | 2 | ACh | 5.9 | 3.0% | 0.1 |
| VP4+VL1_l2PN (R) | 1 | ACh | 5.6 | 2.8% | 0.0 |
| lLN2X12 (L) | 5 | ACh | 5.6 | 2.8% | 0.3 |
| VP4+VL1_l2PN (L) | 1 | ACh | 4.9 | 2.4% | 0.0 |
| lLN2F_a (L) | 2 | unc | 4.2 | 2.1% | 0.1 |
| lLN2P_a (L) | 3 | GABA | 3.8 | 1.9% | 0.6 |
| M_lPNm13 (L) | 4 | ACh | 2.8 | 1.4% | 0.4 |
| lLN2P_b (L) | 3 | GABA | 2.7 | 1.3% | 0.4 |
| v2LN34D (L) | 4 | Glu | 2.4 | 1.2% | 0.7 |
| lLN2X11 (L) | 2 | ACh | 2.4 | 1.2% | 0.3 |
| VL1_vPN (L) | 1 | GABA | 2.3 | 1.1% | 0.0 |
| lLN1_bc (L) | 15 | ACh | 2.2 | 1.1% | 0.6 |
| lLN2T_d (L) | 2 | unc | 1.8 | 0.9% | 0.4 |
| M_lvPNm37 (L) | 2 | ACh | 1.7 | 0.9% | 0.1 |
| il3LN6 (L) | 1 | GABA | 1.2 | 0.6% | 0.0 |
| M_lPNm11A (L) | 3 | ACh | 1 | 0.5% | 0.8 |
| lLN2X05 (L) | 2 | ACh | 1.0 | 0.5% | 0.2 |
| v2LN50 (L) | 4 | Glu | 1.0 | 0.5% | 0.4 |
| lLN2T_e (L) | 2 | ACh | 0.9 | 0.5% | 0.2 |
| M_lvPNm38 (L) | 1 | ACh | 0.7 | 0.3% | 0.0 |
| ALON3 (L) | 2 | Glu | 0.7 | 0.3% | 0.1 |
| v2LN30 (L) | 1 | unc | 0.6 | 0.3% | 0.0 |
| lLN2F_b (L) | 1 | GABA | 0.5 | 0.3% | 0.0 |
| CB3383 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| OA-VUMa2 (M) | 2 | OA | 0.5 | 0.2% | 0.6 |
| lLN2P_c (L) | 2 | GABA | 0.4 | 0.2% | 0.2 |
| M_l2PNl20 (L) | 1 | ACh | 0.3 | 0.2% | 0.0 |
| CB3679 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| vLN24 (L) | 2 | ACh | 0.2 | 0.1% | 0.2 |
| ALIN5 (R) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| VP1d+VP4_l2PN2 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| M_lPNm11B (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| VP1l+_lvPN (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| SAD071 (L) | 1 | GABA | 0.1 | 0.1% | 0.0 |
| M_lvPNm35 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| vLN26 (L) | 1 | unc | 0.1 | 0.0% | 0.0 |
| M_lPNm12 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| M_lPNm11A (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| v2LN39a (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| v2LN34A (L) | 2 | Glu | 0.1 | 0.0% | 0.0 |
| M_imPNl92 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| lLN1_a (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| ORN_VA7l | 1 | ACh | 0.0 | 0.0% | 0.0 |
| OA-VUMa5 (M) | 1 | OA | 0.0 | 0.0% | 0.0 |
| M_smPN6t2 (R) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| CB3417 (L) | 1 | unc | 0.0 | 0.0% | 0.0 |
| VP5+Z_adPN (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| DNc02 (R) | 1 | unc | 0.0 | 0.0% | 0.0 |
| il3LN6 (R) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| v2LN34F (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| vLN25 (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |